Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:55 Issue:1 Number:2 ISSN#:2564-2537
ACE Report #13712
Ace Report Cover Shoulder & Elbow

Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients

How to Cite

OrthoEvidence. Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients. ACE Report. 2021;55(1):2. Available from: https://myorthoevidence.com/AceReport/Report/13712

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effects of myofascial release on frequency of joint bleedings, joint status, and joint pain in patients with hemophilic elbow arthropathy: A randomized, single-blind clinical trial

Medicine (Baltimore). 2021 May 21;100(20): e26025.

Contributing Authors: R Cuesta-Barriuso R Pérez-Llanes E Donoso-Úbeda JA López-Pina J Meroño-Gallut

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Sixty-nine patients with hemophilic elbow arthropathy were included in this randomized controlled trial comparing 3 weeks of myofascial release therapy (n=35) to control (n=34) for the reduction of elbow joint hemarthrosis. The primary outcome of interest was the frequency of hemarthrosis. Secondary outcomes of interest included joint status on the hemophilia joint health score (HJHS) and joint pa...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.